vs
STANDARD BIOTOOLS INC.（LAB）与Outdoor Holding Co（POWW）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Outdoor Holding Co的1.5倍（$19.6M vs $13.4M），Outdoor Holding Co净利率更高（16.7% vs -177.4%，领先194.1%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -54.1%），Outdoor Holding Co自由现金流更多（$5.0M vs $-23.1M）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Vista Outdoor Inc.（原代码POWW）是美国户外行业企业，主营射击运动器材与户外产品两大业务板块，是拥有超过40个品牌与子品牌的多品牌户外用品集团，负责产品的设计、生产与市场推广。
LAB vs POWW — 直观对比
营收规模更大
LAB
是对方的1.5倍
$13.4M
营收增速更快
LAB
高出42.6%
-54.1%
净利率更高
POWW
高出194.1%
-177.4%
自由现金流更多
POWW
多$28.1M
$-23.1M
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $13.4M |
| 净利润 | $-34.7M | $2.2M |
| 毛利率 | 48.5% | 87.1% |
| 营业利润率 | -168.5% | 14.7% |
| 净利率 | -177.4% | 16.7% |
| 营收同比 | -11.5% | -54.1% |
| 净利润同比 | -28.8% | 108.5% |
| 每股收益（稀释后） | $-0.09 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABPOWW
| Q4 25 | — | $13.4M | ||
| Q3 25 | $19.6M | $12.0M | ||
| Q2 25 | $21.8M | $11.9M | ||
| Q1 25 | $40.8M | $12.6M | ||
| Q4 24 | — | $12.5M | ||
| Q3 24 | $22.1M | $12.0M | ||
| Q2 24 | $22.5M | $12.3M | ||
| Q1 24 | $45.5M | $-50.7M |
净利润LABPOWW
| Q4 25 | — | $2.2M | ||
| Q3 25 | $-34.7M | $1.4M | ||
| Q2 25 | $-33.5M | $-6.5M | ||
| Q1 25 | $-26.0M | $-77.5M | ||
| Q4 24 | — | $-26.1M | ||
| Q3 24 | $-26.9M | $-12.4M | ||
| Q2 24 | $-45.7M | $-14.8M | ||
| Q1 24 | $-32.2M | $-5.2M |
毛利率LABPOWW
| Q4 25 | — | 87.1% | ||
| Q3 25 | 48.5% | 87.1% | ||
| Q2 25 | 48.8% | 87.2% | ||
| Q1 25 | 48.4% | 87.5% | ||
| Q4 24 | — | 87.4% | ||
| Q3 24 | 54.9% | 86.9% | ||
| Q2 24 | 46.1% | 85.8% | ||
| Q1 24 | 53.1% | — |
营业利润率LABPOWW
| Q4 25 | — | 14.7% | ||
| Q3 25 | -168.5% | 5.9% | ||
| Q2 25 | -118.1% | -50.7% | ||
| Q1 25 | -80.8% | -213.6% | ||
| Q4 24 | — | -163.8% | ||
| Q3 24 | -120.9% | -50.3% | ||
| Q2 24 | -134.5% | -50.8% | ||
| Q1 24 | -132.2% | — |
净利率LABPOWW
| Q4 25 | — | 16.7% | ||
| Q3 25 | -177.4% | 11.7% | ||
| Q2 25 | -153.7% | -54.5% | ||
| Q1 25 | -63.8% | -614.5% | ||
| Q4 24 | — | -208.7% | ||
| Q3 24 | -122.0% | -103.7% | ||
| Q2 24 | -203.3% | -120.2% | ||
| Q1 24 | -70.6% | 10.3% |
每股收益（稀释后）LABPOWW
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.09 | $0.01 | ||
| Q2 25 | $-0.09 | $-0.06 | ||
| Q1 25 | $-0.07 | $-0.67 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | $-0.07 | $-0.11 | ||
| Q2 24 | $-0.12 | $-0.13 | ||
| Q1 24 | $-0.27 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $69.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $237.3M |
| 总资产 | $539.6M | $271.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABPOWW
| Q4 25 | — | $69.9M | ||
| Q3 25 | $129.4M | $65.7M | ||
| Q2 25 | $158.6M | $63.4M | ||
| Q1 25 | $150.9M | $30.2M | ||
| Q4 24 | — | $31.9M | ||
| Q3 24 | $210.6M | $33.5M | ||
| Q2 24 | $269.8M | $50.8M | ||
| Q1 24 | $287.1M | $55.6M |
总债务LABPOWW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABPOWW
| Q4 25 | — | $237.3M | ||
| Q3 25 | $399.7M | $235.4M | ||
| Q2 25 | $424.5M | $222.5M | ||
| Q1 25 | $454.6M | $222.0M | ||
| Q4 24 | — | $299.6M | ||
| Q3 24 | $489.3M | $325.6M | ||
| Q2 24 | $510.3M | $342.5M | ||
| Q1 24 | $577.3M | $358.0M |
总资产LABPOWW
| Q4 25 | — | $271.7M | ||
| Q3 25 | $539.6M | $270.3M | ||
| Q2 25 | $557.0M | $269.5M | ||
| Q1 25 | $579.6M | $297.3M | ||
| Q4 24 | — | $355.4M | ||
| Q3 24 | $681.5M | $368.9M | ||
| Q2 24 | $708.7M | $398.6M | ||
| Q1 24 | $777.7M | $403.0M |
负债/权益比LABPOWW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $5.7M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $5.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 37.6% |
| 资本支出强度资本支出/营收 | 4.5% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 2.55× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-2.3M |
8季度趋势，按日历期对齐
经营现金流LABPOWW
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-22.2M | $3.2M | ||
| Q2 25 | $-20.7M | $-6.7M | ||
| Q1 25 | $-30.3M | $-1.5M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $-27.9M | $-9.3M | ||
| Q2 24 | $-39.0M | $-547.5K | ||
| Q1 24 | $-62.5M | $4.3M |
自由现金流LABPOWW
| Q4 25 | — | $5.0M | ||
| Q3 25 | $-23.1M | $2.5M | ||
| Q2 25 | $-22.6M | $-7.6M | ||
| Q1 25 | $-35.3M | $-2.3M | ||
| Q4 24 | — | $720.3K | ||
| Q3 24 | $-30.1M | $-10.6M | ||
| Q2 24 | $-41.0M | $-1.3M | ||
| Q1 24 | $-63.3M | $1.4M |
自由现金流率LABPOWW
| Q4 25 | — | 37.6% | ||
| Q3 25 | -118.1% | 21.0% | ||
| Q2 25 | -103.6% | -63.8% | ||
| Q1 25 | -86.6% | -18.6% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | -136.4% | -88.3% | ||
| Q2 24 | -182.2% | -11.0% | ||
| Q1 24 | -138.9% | -2.8% |
资本支出强度LABPOWW
| Q4 25 | — | 4.8% | ||
| Q3 25 | 4.5% | 5.8% | ||
| Q2 25 | 8.7% | 7.5% | ||
| Q1 25 | 12.4% | 6.5% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | 10.2% | 10.4% | ||
| Q2 24 | 8.6% | 6.5% | ||
| Q1 24 | 1.7% | -5.7% |
现金转化率LABPOWW
| Q4 25 | — | 2.55× | ||
| Q3 25 | — | 2.29× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
POWW
暂无分部数据
